Department of Infection and Immunity, University of Sheffield, Medical School, Sheffield, U.K.
Biosci Rep. 2012 Dec;32(6):653-60. doi: 10.1042/BSR20120088.
We have investigated the interaction between GH (growth hormone) and GHR (GH receptor). We previously demonstrated that a truncated GHR that possesses a transmembrane domain but no cytoplasmic domain blocks receptor signalling. Based on this observation we investigated the impact of tethering the receptor's extracellular domain to the cell surface using a native lipid GPI (glycosylphosphatidylinositol) anchor. We also investigated the effect of tethering GH, the ligand itself, to the cell surface and demonstrated that tethering either the ecGHR (extracellular domain of GHR) or the ligand itself to the cell membrane via a GPI anchor greatly attenuates signalling. To elucidate the mechanism for this antagonist activity, we used confocal microscopy to examine the fluorescently modified ligand and receptor. GH-GPI was expressed on the cell surface and formed inactive receptor complexes that failed to internalize and blocked receptor activation. In conclusion, contrary to expectation, tethering an agonist to the cell surface can generate an inactive hormone receptor complex that fails to internalize.
我们研究了 GH(生长激素)和 GHR(GH 受体)之间的相互作用。我们之前的研究表明,一种具有跨膜结构域但没有细胞质结构域的截断 GHR 可以阻断受体信号转导。基于这一观察结果,我们研究了使用天然脂质 GPI(糖基磷脂酰肌醇)锚将受体的细胞外结构域固定在细胞表面的影响。我们还研究了将配体 GH 本身固定在细胞表面的影响,并证明通过 GPI 锚将 ecGHR(GHR 的细胞外结构域)或配体本身固定在细胞膜上,会大大减弱信号转导。为了阐明这种拮抗剂活性的机制,我们使用共聚焦显微镜检查了荧光修饰的配体和受体。GH-GPI 表达在细胞表面,形成不能内化的无活性受体复合物,并阻断受体激活。总之,与预期相反,将激动剂固定在细胞表面会产生不能内化的无活性激素受体复合物。